OlympiAD olaparib | 動物用藥查詢網
![OlympiAD olaparib](https://i.imgur.com/TbfVXFL.jpg)
AssessmentoftheEfficacyandSafetyofOlaparibMonotherapyVersusPhysiciansChoiceChemotherapyintheTreatmentofMetastaticBreastCancerPatientsWith ...,Mostcommonadversereactions(Grades1-4)in≥20%ofpatientswhoreceivedLYNPARZAinthemetastaticsettingforOlympiADwere:nausea(58%),anemia(40%), ...,由MRobson著作·2017·被引用2397次—TheOlympiADtrialwasarandomized,controlled,open-label,multicenter,international,phase3trial.Randomizationwasstratifiedaccording ...,由SAIm著作·2020·被引用17次—TheOlympiADPhaseIIIstudy(...
OlympiAD trial EMBRACA trial IMpassion130 Kn355 Olaparib BRCA SOLO-1 KEYNOTE-355 Talazoparib OlympiAD trial Talazoparib Brocade 3 trial parp抑制劑 olaparib中文 parp是什麼 parp抑制劑價格 Olaparib parp inhibitor健保給付 parp抑制劑副作用 PARP inhibitor DESTINY trial EMBRACA trial PROfound trial OlympiAD olaparib Nabpaclitaxel Nct02000622 Olaparib BRCA talazoparib仿單 talazoparib中文 talazoparib健保 talzenna仿單 VITRAKVI Talazoparib mce 達勝癌 穿剌用液態雞痘活毒疫苗 鐵劑副作用變胖 原子碘副作用 可口可樂600ml價格7-11 7-11可樂價錢 lansoprazole價格 安保英文 杏輝官網
Full Text View | 動物用藥查詢網
Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With ... Read More
LYNPARZA® (olaparib) Efficacy for gBRCAm | 動物用藥查詢網
Most common adverse reactions (Grades 1-4) in ≥20% of patients who received LYNPARZA in the metastatic setting for OlympiAD were: nausea (58%), anemia (40%), ... Read More
Olaparib for Metastatic Breast Cancer in Patients with a ... | 動物用藥查詢網
由 M Robson 著作 · 2017 · 被引用 2397 次 — The OlympiAD trial was a randomized, controlled, open-label, multicenter, international, phase 3 trial. Randomization was stratified according ... Read More
Olaparib monotherapy for Asian patients with a germline ... | 動物用藥查詢網
由 SA Im 著作 · 2020 · 被引用 17 次 — The OlympiAD Phase III study (NCT02000622) established the clinical benefits of olaparib tablet monotherapy (300 mg twice daily) over ... Read More
OlympiAD extended follow | 動物用藥查詢網
由 ME Robson 著作 · 2023 · 被引用 4 次 — Abstract. Background. In the Phase III OlympiAD study, olaparib significantly prolonged progression-free survival versus chemotherapy treatment ... Read More
OlympiAD final overall survival and tolerability results | 動物用藥查詢網
由 ME Robson 著作 · 2019 · 被引用 469 次 — In the OlympiAD study, olaparib was shown to improve progression-free survival compared with chemotherapy treatment of physician's choice (TPC) in patients ... Read More
OlympiAD final overall survival and tolerability results | 動物用藥查詢網
由 ME Robson 著作 · 2019 · 被引用 469 次 — In the OlympiAD study, olaparib was shown to improve progression-free survival compared with chemotherapy treatment of physician's choice ... Read More
OlympiAD final overall survival and tolerability results | 動物用藥查詢網
由 ME Robson 著作 · 2019 · 被引用 469 次 — Background: In the OlympiAD study, olaparib was shown to improve progression-free survival compared with chemotherapy treatment of physician's choice (TPC) in ... Read More
相關資訊整理
![](https://i.imgur.com/TbfVXFL.jpg)
高化維五○○ COFAVIT 500
高化維五○○有哪些副作用?由東盈實業股份有限公司製造的高化維五○○是治療什麼的?藥品成分是什麼?以下為大家提供詳細的「高...
![](https://i.imgur.com/TbfVXFL.jpg)
速滅淨 33% SULMEZINE 33% INJ.
速滅淨33%有哪些副作用?由公源藥品股份有限公司觀音廠製造的速滅淨33%是治療什麼的?藥品成分是什麼?以下為大家提供詳細的...